Detlev Biniszkiewicz, Director at iTeos Therapeutics, Inc. (ITOS), sold 3,500 shares at $51.90 ($182K) on 2022-01-03, disclosed to the SEC on 2022-01-04.
Open-market sale of $182k ITOS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.